The exact mechanism through which pioglitazone affords protection in neurodegenerative diseases has not been conclusively determined, but it is well known that this drug acts as an agonist for peroxisome proliferator-activated receptor gamma (PPARγ), a member of the nuclear hormone receptor family. The gene discussed is PPARG; the disease is neurodegenerative disease.